Lipid homeostasis and mevalonate pathway in COVID-19: Basic concepts and potential therapeutic targets

Pombo, 2018, Perturbation of intracellular cholesterol and fatty acid homeostasis during flavivirus infections, Front Immunol, 9, 10.3389/fimmu.2018.01276 Taube, 2010, Glycosphingolipids as receptors for non-enveloped viruses, Viruses, 2, 1011, 10.3390/v2041011 Mazzon, 2014, Lipid interactions during virus entry and infection, Cell Microbiol, 16, 1493, 10.1111/cmi.12340 Coil, 2005, Enhancement of enveloped virus entry by phosphatidylserine, J Virol, 79, 11496, 10.1128/JVI.79.17.11496-11500.2005 Yamamoto, 2016, Lipoprotein receptors redundantly participate in entry of hepatitis C virus, PLoS Pathog, 12, 10.1371/journal.ppat.1005610 Lyu, 2015, Roles of lipoprotein receptors in the entry of hepatitis C virus, World J Hepatol, 7, 2535, 10.4254/wjh.v7.i24.2535 Zawada, 2016, Influenza viral membrane fusion is sensitive to sterol concentration but surprisingly robust to sterol chemical identity, Sci Rep, 6, 10.1038/srep29842 Heaton, 2011, Multifaceted roles for lipids in viral infection, Trends Microbiol, 19, 368, 10.1016/j.tim.2011.03.007 Guo, 2017, The important role of lipid raft-mediated attachment in the infection of cultured cells by coronavirus infectious bronchitis virus beaudette strain, PLoS One, 12 Radenkovic, 2020, Cholesterol in relation to COVID-19: should we care about it?, J Clin Med, 9, 1909, 10.3390/jcm9061909 Abu-Farha, 2020, The role of lipid metabolism in COVID-19 virus infection and as a drug target, Int J Mol Sci, 21, 10.3390/ijms21103544 Blanchard, 2015, Virus-induced double-membrane vesicles, Cell Microbiol, 17, 45, 10.1111/cmi.12372 Strating, 2017, Viral rewiring of cellular lipid metabolism to create membranous replication compartments, Curr Opin Cell Biol, 47, 24, 10.1016/j.ceb.2017.02.005 Heaton, 2010, Dengue virus-induced autophagy regulates lipid metabolism, Cell Host Microbe, 8, 422, 10.1016/j.chom.2010.10.006 Yuan, 2019, SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target, Nat Commun, 10, 10.1038/s41467-018-08015-x Soto-Acosta, 2013, The increase in cholesterol levels at early stages after dengue virus infection correlates with an augment in LDL particle uptake and HMG-CoA reductase activity, Virology, 442, 132, 10.1016/j.virol.2013.04.003 Yu, 2012, Human cytomegalovirus infection induces adipocyte-like lipogenesis through activation of sterol regulatory element binding protein 1, J Virol, 86, 2942, 10.1128/JVI.06467-11 Lee, 2020, COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm, Signal Transduct Target Ther, 5 Kotzamanis, 2015, Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection, Med Microbiol Immunol, 204, 395, 10.1007/s00430-015-0402-5 Gold, 2014, 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling, Proc Natl Acad Sci U S A, 111, 10666, 10.1073/pnas.1404271111 Yi, 2006, HIV gp120-induced interaction between CD4 and CCR5 requires cholesterol-rich microenvironments revealed by live cell fluorescence resonance energy transfer imaging, J Biol Chem, 281, 35446, 10.1074/jbc.M607302200 Liu, 2006, Role of simvastatin and methyl-β-cyclodextin on inhibition of poliovirus infection, Biochem Biophys Res Commun, 347, 51, 10.1016/j.bbrc.2006.06.107 Moriyama, 2008, Repression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin, Transplantation, 85, 1311, 10.1097/TP.0b013e31816c4ec5 Wang, 2015, Mono-ubiquitylated ORF45 mediates association of KSHV particles with internal lipid rafts for viral assembly and egress, PLoS Pathog, 11, 10.1371/journal.ppat.1005332 Glende, 2008, Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2, Virology, 381, 215, 10.1016/j.virol.2008.08.026 Fedson, 2015, Treating Ebola patients: a “bottom up” approach using generic statins and angiotensin receptor blockers, Int J Infect Dis, 36, 25, 10.1016/j.ijid.2015.04.019 Shrivastava-Ranjan, 2018, Statins suppress Ebola virus infectivity by interfering with glycoprotein processing, MBio, 9, 10.1128/mBio.00660-18 Españo, 2019, Lipophilic statins inhibit Zika virus production in Vero cells, Sci Rep, 9, 10.1038/s41598-019-47956-1 Wang, 2019, Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival, PLoS Pathog, 15, 10.1371/journal.ppat.1008030 Del Real, 2004, Statins inhibit HIV-1 infection by down-regulating Rho activity, J Exp Med, 200, 541, 10.1084/jem.20040061 Gower, 2001, Antiviral activity of lovastatin against respiratory syncytial virus in vivo and in vitro, Antimicrob Agents Chemother, 45, 1231, 10.1128/AAC.45.4.1231-1237.2001 Haidari, 2007, Statins block influenza infection by down-regulating rho/rho kinase pathway, Circulation, 116, 116 Mehrbod, 2014, Simvastatin modulates cellular components in influenza A virus-infected cells, Int J Mol Med, 34, 61, 10.3892/ijmm.2014.1761 Episcopio, 2019, Atorvastatin restricts the ability of influenza virus to generate lipid droplets and severely suppresses the replication of the virus, FASEB J, 33, 9516, 10.1096/fj.201900428RR Ikeda, 2006, Different anti-HCV profiles of statins and their potential for combination therapy with interferon, Hepatology, 44, 117, 10.1002/hep.21232 Subir, 2020, Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19), Diabetes Metab Syndr Clin Res Rev, 14, 1225, 10.1016/j.dsx.2020.07.011 Rothwell, 2009, Cholesterol biosynthesis modulation regulates dengue viral replication, Virology, 389, 8, 10.1016/j.virol.2009.03.025 Brufsky, 2020, Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection, J Transl Med, 18, 10.1186/s12967-020-02433-6 Sen, 2014, Investigating the efficacy of pamidronate, a chemical inhibitor of farnesyl pyrophosphate synthase, in the inhibition of influenza virus infection in vitro and in vivo, Mol Med Rep, 9, 51, 10.3892/mmr.2013.1750 Budd, 2007, Increased survival after gemfibrozil treatment of severe mouse influenza, Antimicrob Agents Chemother, 51, 2965, 10.1128/AAC.00219-07 Fujita, 2006, Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin, J Viral Hepat, 13, 441, 10.1111/j.1365-2893.2005.00718.x Buschard, 2020, Fenofibrate increases the amount of sulfatide which seems beneficial against Covid-19, Med Hypotheses, 143, 10.1016/j.mehy.2020.110127 Scicali, 2020, May statins and PCSK9 inhibitors be protective from COVID-19 in familial hypercholesterolemia subjects?, Nutr Metab Cardiovasc Dis, 30, 1068, 10.1016/j.numecd.2020.05.003 Huwiler, 2018, The sphingosine 1-phosphate receptor modulator fingolimod as a therapeutic agent: recent findings and new perspectives, Pharmacol Ther, 185, 34, 10.1016/j.pharmthera.2017.11.001 Bifulco, 2020, Statin therapy in COVID-19 infection: much more than a single pathway, Eur Hear J Cardiovasc Pharmacother, 6, 410, 10.1093/ehjcvp/pvaa055 Truwit, 2014, Rosuvastatin for sepsis-associated acute respiratory distress syndrome, N Engl J Med, 370, 2191, 10.1056/NEJMoa1401520 McAuley, 2014, Simvastatin in the acute respiratory distress syndrome, N Engl J Med, 371, 1695, 10.1056/NEJMoa1403285 Calfee, 2018, Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial, Lancet Respir Med, 6, 691, 10.1016/S2213-2600(18)30177-2 Calza, 2017, Significant decrease in plasma levels of d-dimer, interleukin-8, and interleukin-12 after a 12-month treatment with rosuvastatin in HIV-infected patients under antiretroviral therapy, AIDS Res Hum Retroviruses, 33, 126, 10.1089/aid.2016.0134 Xia, 2018, The mevalonate pathway is a druggable target for vaccine adjuvant discovery, Cell, 175, 10.1016/j.cell.2018.08.070 Bird, 2018, Statins as adjuvants, Nat Rev Immunol, 18, 669, 10.1038/s41577-018-0076-5 Reiner, 2020, Statins and the COVID-19 main protease: in silico evidence on direct interaction, Arch Med Sci, 16, 490, 10.5114/aoms.2020.94655 Goyal, 2020, Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy, ACS Comb Sci, 22, 297, 10.1021/acscombsci.0c00058 Ayres, 2012, Tolerance of infections, Annu Rev Immunol, 30, 271, 10.1146/annurev-immunol-020711-075030 Medzhitov, 2007, Recognition of microorganisms and activation of the immune response, Nature, 449, 819, 10.1038/nature06246 Taniguchi, 2002, The interferon-α/β system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors, Curr Opin Immunol, 14, 111, 10.1016/S0952-7915(01)00305-3 Gaudino, 2019, Cross-talk between antigen presenting cells and T cells impacts intestinal homeostasis, bacterial infections, and tumorigenesis, Front Immunol, 10, 10.3389/fimmu.2019.00360 Tisoncik, 2012, Into the eye of the cytokine storm, Microbiol Mol Biol Rev, 76, 16, 10.1128/MMBR.05015-11 Bermejo-Martin, 2009, Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza, Crit Care, 13, 10.1186/cc8208 Favre, 2009, Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection, PLoS Pathog, 5, 10.1371/journal.ppat.1000295 Rowan, 2008, Hepatitis C virus-specific Th17 cells are suppressed by virus-induced TGF-β, J Immunol, 181, 4485, 10.4049/jimmunol.181.7.4485 Culley, 2006, Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology, J Virol, 80, 4521, 10.1128/JVI.80.9.4521-4527.2006 Dörner, 2007, Antibodies and B cell memory in viral immunity, Immunity, 27, 384, 10.1016/j.immuni.2007.09.002 Rouse, 2010, Immunity and immunopathology to viruses: what decides the outcome?, Nat Rev Immunol, 10, 514, 10.1038/nri2802 Chen, 1994, Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis, Science (80-), 265, 1237, 10.1126/science.7520605 Groux, 1997, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389, 737, 10.1038/39614 Kiniwa, 2007, CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer, Clin Cancer Res, 13, 6947, 10.1158/1078-0432.CCR-07-0842 Sakaguchi, 2005, Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self, Nat Immunol, 6, 345, 10.1038/ni1178 Taniguchi, 2003, The regulatory role of Vα14 NKT cells in innate and acquired immune response, Annu Rev Immunol, 21, 483, 10.1146/annurev.immunol.21.120601.141057 Terrazzano, 2020, Type 1 diabetes progression is associated with loss of CD3+CD56+ regulatory T cells that control CD8+ T-cell effector functions, Nat Metab, 2, 142, 10.1038/s42255-020-0173-1 Li, 2008, Contextual regulation of inflammation: a duet by transforming growth factor-β and interleukin-10, Immunity, 28, 468, 10.1016/j.immuni.2008.03.003 Law, 2020, A pro-resolving role for galectin-1 in acute inflammation, Front Pharmacol, 11, 10.3389/fphar.2020.00274 Serhan, 2011, Resolvins and protectins in inflammation resolution, Chem Rev, 111, 5922, 10.1021/cr100396c Schnell, 2020, The yin and yang of co-inhibitory receptors: toward anti-tumor immunity without autoimmunity, Cell Res, 30, 285, 10.1038/s41422-020-0277-x Rudensky, 2011, Regulatory T cells and Foxp3, Immunol Rev, 241, 260, 10.1111/j.1600-065X.2011.01018.x Veiga-Parga, 2012, On the role of regulatory T cells during viral-induced inflammatory lesions, J Immunol, 189, 5924, 10.4049/jimmunol.1202322 Bruzzaniti, 2019, An immunometabolic pathomechanism for chronic obstructive pulmonary disease, Proc Natl Acad Sci U S A, 116, 15625, 10.1073/pnas.1906303116 Wedzicha, 2004, Role of viruses in exacerbations of chronic obstructive pulmonary disease, Proc Am Thorac Soc, 1, 115, 10.1513/pats.2306030 Luo, 2020, Mechanisms and regulation of cholesterol homeostasis, Nat Rev Mol Cell Biol, 21, 225, 10.1038/s41580-019-0190-7 Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver, J Clin Invest, 109, 1125, 10.1172/JCI0215593 Bietz, 2017, Cholesterol metabolism in T cells, Front Immunol, 8, 10.3389/fimmu.2017.01664 Puleston, 2017, Ancillary activity: beyond core metabolism in immune cells, Cell Metab, 26, 131, 10.1016/j.cmet.2017.06.019 Zelcer, 2006, Liver X receptors as integrators of metabolic and inflammatory signaling, J Clin Invest, 116, 607, 10.1172/JCI27883 Joseph, 2003, Reciprocal regulation of inflammation and lipid metabolism by liver X receptors, Nat Med, 9, 213, 10.1038/nm820 Joseph, 2004, LXR-dependent gene expression is important for macrophage survival and the innate immune response, Cell, 119, 299, 10.1016/j.cell.2004.09.032 Bensinger, 2008, LXR signaling couples sterol metabolism to proliferation in the acquired immune response, Cell, 134, 97, 10.1016/j.cell.2008.04.052 Kidani, 2013, Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity, Nat Immunol, 14, 489, 10.1038/ni.2570 Acharya, 2019, Mevalonate promotes differentiation of regulatory T cells, J Mol Med, 97, 927, 10.1007/s00109-019-01784-y Timilshina, 2019, Activation of mevalonate pathway via LKB1 is essential for stability of Treg cells, Cell Rep, 27, 10.1016/j.celrep.2019.05.020 Zeng, 2013, MTORC1 couples immune signals and metabolic programming to establish T reg-cell function, Nature, 499, 485, 10.1038/nature12297 Karmaus, 2019, Effects of rosuvastatin on the immune system in healthy volunteers with normal serum cholesterol, JCI Insight, 4, 10.1172/jci.insight.131530 Jain, 2005, Anti-inflammatory effects of statins: clinical evidence and basic mechanisms, Nat Rev Drug Discov, 4, 977, 10.1038/nrd1901 Spann, 2013, Sterols and oxysterols in immune cell function, Nat Immunol, 14, 893, 10.1038/ni.2681 Kuipers, 2007, Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis, Biomed Pharmacother, 61, 400, 10.1016/j.biopha.2007.06.005 Giguère, 2004, Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1, J Virol, 78, 12062, 10.1128/JVI.78.21.12062-12065.2004 Nabatov, 2007, Statins disrupt CCR5 and RANTES expression levels in CD4+ T lymphocytes In vitro and preferentially decrease infection of R5 versus X4 HIV-1, PLoS One, 2, 10.1371/journal.pone.0000470 Del Real, 2002, Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains, J Exp Med, 196, 293, 10.1084/jem.20020308 Liao, 2001, Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1, AIDS Res Hum Retroviruses, 17, 1009, 10.1089/088922201300343690 Elahi, 2016, Atorvastatin restricts HIV replication in CD4+ T cells by upregulation of p21, Aids, 30, 171, 10.1097/QAD.0000000000000917 Fu, 2019, The differential statin effect on cytokine production of monocytes or macrophages is mediated by differential geranylgeranylation-dependent Rac1 activation, Cell Death Dis, 10, 10.1038/s41419-019-2109-9 Youssef, 2002, The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease, Nature, 420, 78, 10.1038/nature01158 Arora, 2006, Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells, Proc Natl Acad Sci U S A, 103, 7777, 10.1073/pnas.0508492103 Aslangul, 2011, High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors, Aids, 25, 1128, 10.1097/QAD.0b013e328346be29 Calza, 2014, Tenofovir/emtricitabine/efavirenz plus rosuvastatin decrease serum levels of inflammatory markers more than antiretroviral drugs alone in antiretroviral therapy-naive hiv-infected patients, HIV Clin Trials, 15, 1, 10.1310/hct1501-1 Funderburg, 2015, Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy, J Acquir Immune Defic Syndr, 68, 396, 10.1097/QAI.0000000000000478 Ganesan, 2011, High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial, J Infect Dis, 203, 756, 10.1093/infdis/jiq115 Jameson, 2010, A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human γδ T lymphocytes, Cell Immunol, 264, 71, 10.1016/j.cellimm.2010.04.013 Katano, 2004, Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas, Proc Natl Acad Sci U S A, 101, 4960, 10.1073/pnas.0305149101 Narayan, 2003, Attenuated T-lymphocyte response to HIV therapy in individuals receiving HMG-CoA reductase inhibitors, HIV Clin Trials, 4, 164, 10.1310/B05E-TFVN-UJ8L-MFHJ Tu, 2011, The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a γδ T cell population in humanized mice, J Exp Med, 208, 1511, 10.1084/jem.20110226 Poccia, 2009, Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vγ9Vδ2 T cells, Aids, 23, 555, 10.1097/QAD.0b013e3283244619 Fessler, 2016, The intracellular cholesterol landscape: dynamic integrator of the immune response, Trends Immunol, 37, 819, 10.1016/j.it.2016.09.001 Zang, 2020, Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion, Proc Natl Acad Sci U S A, 117, 32105, 10.1073/pnas.2012197117 Cyster, 2014, 25-hydroxycholesterols in innate and adaptive immunity, Nat Rev Immunol, 14, 731, 10.1038/nri3755 Zu, 2020, 25-hydroxycholesterol is a potent SARS-CoV-2 inhibitor, Cell Res, 30, 1043, 10.1038/s41422-020-00398-1 Hu, 2012, MicroRNAs 125a and 455 repress lipoprotein-supported steroidogenesis by targeting scavenger receptor class B type I in steroidogenic cells, Mol Cell Biol, 32, 5035, 10.1128/MCB.01002-12 Larsen, 2011, Expression and localization of microRNAs in perinatal rat pancreas: role of miR-21 in regulation of cholesterol metabolism, PLoS One, 6, 10.1371/journal.pone.0025997 Miller, 2013, MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice, PLoS One, 8, 10.1371/journal.pone.0072324 Ramírez, 2013, Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144, Circ Res, 112, 1592, 10.1161/CIRCRESAHA.112.300626 Yang, 2014, Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake, J Lipid Res, 55, 226, 10.1194/jlr.M041335 Robertson, 2016, An interferon regulated microRNA provides broad cell-intrinsic Antiviral immunity through multihit host-directed targeting of the sterol pathway, PLoS Biol, 14, 10.1371/journal.pbio.1002364 York, 2015, Limiting cholesterol biosynthetic flux spontaneously engages type i IFN signaling, Cell, 163, 1716, 10.1016/j.cell.2015.11.045 Lin, 2003, Cholesterol requirement of hepatitis B surface antigen (HBsAg) secretion, Virology, 314, 253, 10.1016/S0042-6822(03)00403-3 Bader, 2010, Simvastatin potentiates the anti-hepatitis B virus activity of FDA-approved nucleoside analogue inhibitors in vitro, Antiviral Res, 86, 241, 10.1016/j.antiviral.2010.02.325 Chauvin, 2013, Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors, Clin Pharmacokinet, 52, 815, 10.1007/s40262-013-0075-4 Newman, 2019, Statin safety and associated adverse events a scientific statement from the American Heart Association, Arterioscler Thromb Vasc Biol, 39, E38, 10.1161/ATV.0000000000000073 Tsan, 2012, Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection, J Clin Oncol, 30, 623, 10.1200/JCO.2011.36.0917 Chang, 2017, Statins decrease the risk of decompensation in hepatitis B virus– and hepatitis C virus–related cirrhosis: a population-based study, Hepatology, 66, 896, 10.1002/hep.29172 Chen, 2015, Cancer risk in HBV patients with statin and metformin use a population-based cohort study, Med (United States), 94 Oliver, 2016, Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals, Aids, 30, 2469, 10.1097/QAD.0000000000001219 Thaker, 2019, Viral hijacking of cellular metabolism, BMC Biol, 17, 59, 10.1186/s12915-019-0678-9 Lonardo, 2007, Statins and HCV: a complex issue [1], Hepatology, 45, 257, 10.1002/hep.21506 Rao, 2011, Statin therapy improves sustained virologic response among diabetic patients with chronic hepatitis C, Gastroenterology, 140, 10.1053/j.gastro.2010.08.055 Verpaalen, 2014, Are statins a viable option for the treatment of infections with the hepatitis C virus?, Antiviral Res, 105, 92, 10.1016/j.antiviral.2014.02.020 Honore, 2017, Statins and the kidney: friend or foe?, Blood Purif, 43, 91, 10.1159/000453577 Gabardi, 2015, Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia, Transpl Infect Dis, 17, 536, 10.1111/tid.12402 Wu, 2013, Hepatitis B virus reactivation associated with atorvastatin, Int J Infect Dis, 17, e1069, 10.1016/j.ijid.2013.04.001 Zuin, 2019, Herpes zoster infection and statins: which implications in clinical practice?, Eur J Clin Microbiol Infect Dis, 38, 93, 10.1007/s10096-018-3399-z Fan, 2019, Association between statin use and herpes zoster: Systematic review and meta-analysis, BMJ Open, 9, 10.1136/bmjopen-2018-022897 Sutton, 2019, Statin therapy and herpes virus reactivation—response to Zuin et al. paper, Eur J Clin Microbiol Infect Dis, 38, 1195, 10.1007/s10096-019-03513-2 Waghmare, 2019, Human rhinovirus infections in hematopoietic cell transplant recipients: risk score for progression to lower respiratory tract infection, Biol Blood Marrow Transplant, 25, 1011, 10.1016/j.bbmt.2018.12.005 Bajimaya, 2017, Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses, Virology, 510, 234, 10.1016/j.virol.2017.07.024 Mehrbod, 2014, Mechanisms of action and efficacy of statins against influenza, Biomed Res Int, 2014, 10.1155/2014/872370 Fedson, 2008, Confronting an influenza pandemic with inexpensive generic agents: can it be done?, Lancet Infect Dis, 8, 571, 10.1016/S1473-3099(08)70070-7 Kumaki, 2012, Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice, Fut Virol, 7, 801, 10.2217/fvl.12.71 Atamna, 2019, Statins and outcomes of hospitalized patients with laboratory-confirmed 2017–2018 influenza, Eur J Clin Microbiol Infect Dis, 38, 2341, 10.1007/s10096-019-03684-y Tsai, 2020, Statin use and influenza vaccine effectiveness in persons >65 years of age, Taiwan, Emerg Infect Dis, 26, 1243, 10.3201/eid2606.190646 Tonti, 2013, Bisphosphonates target B cells to enhance humoral immune responses, Cell Rep, 5, 323, 10.1016/j.celrep.2013.09.004 Biver, 2017, Bone health in HIV and hepatitis B or C infections, Ther Adv Musculoskelet Dis, 9, 22, 10.1177/1759720X16671927 Huang, 2013, Impact of hepatitis C virus infection on bone mineral density in renal transplant recipients, PLoS One, 8 Premaor, 2020, People living with HIV and fracture risk, Osteoporos Int, 31, 1633, 10.1007/s00198-020-05350-y Ofotokun, 2020, Antiretroviral therapy-induced bone loss is durably suppressed by a single dose of zoledronic acid in treatment-naive persons with human immunodeficiency virus infection: a phase iib trial, Clin Infect Dis, 71, 1655, 10.1093/cid/ciz1027 De Wit, 2016, SARS and MERS: recent insights into emerging coronaviruses, Nat Rev Microbiol, 14, 523, 10.1038/nrmicro.2016.81 Channappanavar, 2017, Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology, Semin Immunopathol, 39, 529, 10.1007/s00281-017-0629-x Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 470, 10.1016/S0140-6736(20)30183-5 Cao, 2020, Cholesterol: a new game player accelerating vasculopathy caused by SARS-CoV-2?, Am J Physiol Endocrinol Metab, 319, E197, 10.1152/ajpendo.00255.2020 Bifulco, 2020, Statins in coronavirus outbreak: it’s time for experimental and clinical studies, Pharmacol Res, 156, 10.1016/j.phrs.2020.104803 Rodrigues-Diez, 2020, Statins: Could an old friend help in the fight against COVID-19?, Br J Pharmacol, 177, 4873, 10.1111/bph.15166 Castiglione, 2020, Statin therapy in COVID-19 infection, Eur Hear J Cardiovasc Pharmacother, 6, 258, 10.1093/ehjcvp/pvaa042 Wu, 2020, SARS-CoV-2 and cardiovascular complications: from molecular mechanisms to pharmaceutical management, Biochem Pharmacol, 178, 10.1016/j.bcp.2020.114114 Vuorio, 2021, Statins as adjuvant therapy for COVID-19 to calm the stormy immunothrombosis and beyond, Front Pharmacol, 11, 10.3389/fphar.2020.579548 Bifulco, 2020, The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed, Endocrine De Spiegeleer, 2020, The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents, J Am Med Dir Assoc, 21, 10.1016/j.jamda.2020.06.018 Rodriguez-Nava, 2020, Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study, Crit Care, 24, 10.1186/s13054-020-03154-4 Gupta, 2021, Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19, Nat Commun, 12, 10.1038/s41467-021-21553-1 Aparisi, 2021, Impact of statins in patients with COVID-19, Rev Española Cardiol Lee, 2021, Beneficial effect of statins in COVID-19-related outcomes-brief report: a National Population-Based Cohort Study, Arterioscler Thromb Vasc Biol, 41, e175, 10.1161/ATVBAHA.120.315551 Zhang, 2020, In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19, Cell Metab, 32, 10.1016/j.cmet.2020.06.015 Kow, 2020, Meta-analysis of effect of statins in patients with COVID-19, Am J Cardiol, 134, 153, 10.1016/j.amjcard.2020.08.004 Hariyanto, 2020, Statin therapy did not improve the in-hospital outcome of coronavirus disease 2019 (COVID-19) infection, Diabetes Metab Syndr Clin Res Rev, 14, 1613, 10.1016/j.dsx.2020.08.023 Pal, 2021, Statin use and clinical outcomes in patients with COVID-19: an updated systematic review and meta-analysis, Postgrad Med J Permana, 2021, In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis, Pharmacol Rep, 10.1007/s43440-021-00233-3 Manson, 2020, COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study, Lancet Rheumatol, 2, e594, 10.1016/S2665-9913(20)30275-7 Wang, 2020, Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study, Lipids Health Dis, 19, 10.1186/s12944-020-01382-9 Ravnskov, 2020, Cholesterol-lowering treatment may worsen the outcome of a Covid-19 infection, BMJ, 368, m1182 Azemawah, 2019, State of the art comprehensive review of individual statins, their differences, pharmacology, and clinical implications, Cardiovasc Drugs Ther, 33, 625, 10.1007/s10557-019-06904-x Qu, 2018, Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials, J Am Heart Assoc, 7, 10.1161/JAHA.118.009835 Deichmann, 2010, Coenzyme Q10 and statin-induced mitochondrial dysfunction, Ochsner J, 10, 16 Coppadoro, 2013, Critical illness is associated with decreased plasma levels of coenzyme Q10: a cross-sectional study, J Crit Care, 28, 571, 10.1016/j.jcrc.2013.02.009 Fan, 2017, Effects of coenzyme Q10 supplementation on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials, Pharmacol Res, 119, 128, 10.1016/j.phrs.2017.01.032 Disser, 2020, Musculoskeletal consequences of COVID-19, J Bone Jt Surg Am Vol, 102, 1197, 10.2106/JBJS.20.00847 Alrubaye, 2020, Severe rhabdomyolysis in a 35-year-old woman with covid-19 due to sars-cov-2 infection: a case report, Am J Case Rep, 21, 1, 10.12659/AJCR.926733 Jin, 2020, Rhabdomyolysis as potential late complication associated with COVID-19, Emerg Infect Dis, 26, 1618, 10.3201/eid2607.200445 Suwanwongse, 2020, Rhabdomyolysis as a presentation of 2019 novel coronavirus disease, Cureus, 10.7759/cureus.7561 Ridruejo, 2020, The liver in times of COVID-19: what hepatologists should know, Ann Hepatol, 19, 353, 10.1016/j.aohep.2020.05.001 Ferrari, 2021, Statins and COVID-19: to suspend or not to suspend? that is the question!, Arq Bras Cardiol, 116, 147, 10.36660/abc.20200949 Fedson, 2020, Statin treatment of COVID-19, Am J Cardiol, 136, 171, 10.1016/j.amjcard.2020.09.050 Zhao, 2009, Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice, PLoS Pathog, 5, 10.1371/journal.ppat.1000636 Wilk, 2020, A single-cell atlas of the peripheral immune response in patients with severe COVID-19, Nat Med, 26, 1070, 10.1038/s41591-020-0944-y Cremers, 2011, Pharmacology of bisphosphonates, Bone, 49, 42, 10.1016/j.bone.2011.01.014 Tanvetyanon, 2006, Management of the adverse effects associated with intravenous bisphosphonates, Ann Oncol, 17, 897, 10.1093/annonc/mdj105 Kim, 2015, Bisphosphonates and risk of cardiovascular events: a meta-analysis, PLoS One, 10 Upadhyaya, 2020, Challenges and strategies in management of osteoporosis and fragility fracture care during COVID-19 pandemic, J Orthop, 21, 287, 10.1016/j.jor.2020.06.001